| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.93B | 20.25B | 20.27B | 20.55B | 15.45B | 12.73B |
| Gross Profit | 11.90B | 12.17B | 12.20B | 12.27B | 9.48B | 7.70B |
| EBITDA | 5.23B | 6.36B | 7.24B | 8.06B | 4.93B | 4.28B |
| Net Income | 2.43B | 2.35B | 3.87B | 4.45B | 3.94B | 2.66B |
Balance Sheet | ||||||
| Total Assets | 50.29B | 49.32B | 45.47B | 44.88B | 36.52B | 31.95B |
| Cash, Cash Equivalents and Short-Term Investments | 2.69B | 2.65B | 1.13B | 1.81B | 2.54B | 2.87B |
| Total Debt | 24.21B | 24.40B | 21.50B | 20.79B | 16.02B | 14.73B |
| Total Liabilities | 36.59B | 36.14B | 33.40B | 33.17B | 27.00B | 23.52B |
| Stockholders Equity | 11.61B | 11.09B | 10.03B | 9.86B | 7.80B | 6.90B |
Cash Flow | ||||||
| Free Cash Flow | 1.63B | 2.69B | 4.55B | 4.33B | 2.84B | 3.03B |
| Operating Cash Flow | 3.22B | 4.30B | 6.07B | 5.74B | 3.94B | 3.65B |
| Investing Cash Flow | -1.48B | -1.72B | -1.59B | -1.43B | -1.34B | -1.09B |
| Financing Cash Flow | -1.87B | -1.49B | -3.11B | -3.04B | -3.26B | -2.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £685.29M | 9.21 | 14.27% | 2.74% | 4.02% | 18.51% | |
75 Outperform | £15.49B | 8.53 | 26.03% | 1.96% | 9.27% | 16.35% | |
70 Outperform | £92.32B | 7.05 | 16.33% | 5.67% | -0.99% | 159.02% | |
66 Neutral | £34.33B | 4.45 | 21.39% | 5.00% | -4.98% | -35.54% | |
65 Neutral | £1.64B | 8.87 | 2.17% | 5.27% | 26.84% | -81.73% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
41 Neutral | £21.60M | -1.63 | ― | ― | ― | ― |